Non-viral causes of hepatocellular carcinoma

Journal of Gastrointestinal Cancer

Volumn 42, Issue 4, 2011, Pages 191-194

  Van Thiel, David H ^a,b   Ramadori, Guiliano ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cancer; Hepatocellular carcinoma; NAFLD; NASH

Indexed keywords

AFLATOXIN; ALPHA 1 ANTITRYPSIN; ORAL CONTRACEPTIVE AGENT;

ALCOHOL LIVER DISEASE; ALPHA 1 ANTITRYPSIN DEFICIENCY; CANCER GROWTH; COPPER METABOLISM; ENVIRONMENTAL EXPOSURE; HUMAN; IRON METABOLISM DISORDER; LIVER CELL CARCINOMA; LIVER DISEASE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REVIEW; TOBACCO;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS;

EID: 81955164274     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9195-3     Document Type: Review

References (48)

1. Ferlay J, Parkin DM, Pisani P, GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. Version 1.0. IARC Cancer Base No. 5. Lyon: IARC; 2004.
2. FX Bosch J Ribes M Diaz R Cleries 2004 Primary liver cancer: worldwide incidence and trends Gastroenterology 127 5 Suppl 1 S5 S16 15508102 10.1053/j.gastro.2004.09.011 (Pubitemid 39423365)
3. HB El-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750 10072408 10.1056/NEJM199903113401001 1:STN:280:DyaK1M7ls1ensg%3D%3D (Pubitemid 29114292)
4. HB El-Serag JA Davila NJ Petersen KA McGlynn 2003 The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 10 817 823 14623619
5. SA Khan SD Taylor-Robinson MB Toledano A Beck P Elliott HC Thomas 2002 Changing international trends in mortality rates for liver, biliary and pancreatic tumours J Hepatol 37 806 813 12445422 10.1016/S0168-8278(02)00297-0 (Pubitemid 35404220)
6. F Levi F Lucchini E Negri P Boyle C La Vecchia 2004 Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960 Int J Cancer 110 2 155 169 15069676 10.1002/ijc.20097 1:CAS:528:DC%2BD2cXjvVeitLo%3D (Pubitemid 38580385)
7. AM Di Bisceglie 1995 Hepatitis C and hepatocellular carcinoma Sem Liver Dis 1995 1564 1569
8. WM Lee 1997 Hepatitis B virus infection N Engl J Med 337 1733 1745 9392700 10.1056/NEJM199712113372406 1:STN:280:DyaK1c%2FktFyjtA%3D%3D (Pubitemid 27527771)
9. FX Bosch J Ribes R Cleries M Diaz 2005 Epidemiology of hepatocellular carcinoma Clin Liver Dis 9 191 211 15831268 10.1016/j.cld.2004.12.009
10. Y Tanaka K Hanada M Mizokami AE Yeo JW Shih T Gojobori HJ Alter 2002 Inaugural article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades Proc Natl Acad Sci USA 99 15584 15589 12438687 10.1073/pnas.242608099 1:CAS:528:DC%2BD3sXjvVyl (Pubitemid 35403976)
11. H Tsukuma T Hiyama S Tanaka M Nakao T Yabuuchi T Kitamura K Nakanishi I Fujimoto A Inoue H Yamazaki T Kawashima 1993 Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1797 1801 7684822 10.1056/NEJM199306243282501 1:STN:280:DyaK3s3nsFektg%3D%3D (Pubitemid 23174709)
12. H Yoshizawa 2002 Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the forseeable future Oncology 62 Suppl 1 8 17 11868791 10.1159/000048270 (Pubitemid 34702014)
13. TJ Liang LJ Jeffers KR Reddy M DeMedina IT Parker H Cheinquer V Idrovo A Rabassa ER Schiff 1993 Viral pathogenesis of hepatocellular carcinoma in the United States Hepatology 18 1326 1333 8244256 1:STN:280:DyaK2c%2FmtlOltw%3D%3D (Pubitemid 23348417)
14. E Bugianesi N Leone E Vanni G Marchesini F Brunello P Carucci A Musso P De Paolis L Capussotti M Salizzoni M Rizzetto 2002 Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 134 140 12105842 10.1053/gast.2002.34168 (Pubitemid 34747534)
15. M Shimada E Hashimoto M Taniai K Hasegawa H Okuda N Hayashi K Takasaki J Ludwig 2002 Hepatocellular carcinoma in patients with non-alchoholic steatohepatitis J Hepatol 37 154 160 12076877 10.1016/S0168-8278(02)00099-5 (Pubitemid 34713069)
16. AS Yu EB Keeffe 2002 Nonalcoholic atty liver disease Rev GE disord 2 11 19
17. K Metha DH Van Thiel N Shah S Mobarhan 2002 Nonalcoholic fatty liver disease; pathogenesis and the role of antioxidants Nutr Rev 60 289 293 10.1301/002966402320387224 (Pubitemid 35025794)
18. AD Baldridge AR Peres-Atayde F Graeme-Cook L Higgins JE Lavi 1995 Idiopathic steatohepatitis in childhood: a multicenter retrospective study J Pediatr 127 700 704 7472819 10.1016/S0022-3476(95)70156-7 1:STN:280: DyaK28%2FmtVyquw%3D%3D
19. ND Manton J Lipsett DM Moore GP Davidson AJ Buourne RTL Couper 2000 Non-alcoholic steatohepatitis in children and adolescents Med J Aust 173 476 479 11149304 1:STN:280:DC%2BD3M7htlCrtw%3D%3D
20. HT Sorensen L Mellemkjaer P Jepsen AM Thulstrup J Baron JH Olsen H Vilstrup 2003 Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study J Clin Gastroenterol 36 4 356 359 12642745 10.1097/00004836- 200304000-00015 (Pubitemid 36331620)
21. K George MM Alberti P Zimmet J Shaw 2005 The metabolic syndrome-a new worldwide definition Lancet 366 1059 1062 10.1016/S0140-6736(05)67402-8 (Pubitemid 41338752)
22. HB El-Serag PA Richardson JE Everhart 2001 The role of diabetes in hepatocellular carcinoma: a case-control study among USA Veterans Amer J GE 96 2462 2467 1:STN:280:DC%2BD3MvmvVKqug%3D%3D (Pubitemid 32769212)
23. P Angulo 2002 Non-alcoholic fatty liver disease New Engl J Med 346 1221 1231 11961152 10.1056/NEJMra011775 1:CAS:528:DC%2BD38XivVOmsrY%3D (Pubitemid 34984585)
24. Van Thiel DH, Ramadori G. Metabolic disease and hepatocellular carcinoma. In: Carr B, editor. Hepatocellular carcinoma diagnosis and treatment, vol. 2. New York: Humana; 2010. p. 283-308.
25. Tal-Kremer S, Day CP, Reeves HL. Genetic basis of hepatocellular cancer. In: Ali S, Friedman SL, Mann DA, editors. Liver diseases biochemical mechanisms and new therapeutic insights. Enfield: Science; 2006. p. 273-308.
26. V Tovar C Alsinet A Villanueva Y Hoshida DY Chiang M Solé S Thung S Moyano S Toffanin B Mínguez L Cabellos J Peix M Schwartz V Mazzaferro J Bruix JM Llovet 2010 IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage J Hepatol 52 4 550 559 20206398 10.1016/j.jhep.2010.01.015 1:CAS:528:DC%2BC3cXjvFKmsb0%3D
27. GE Arteel 2003 Oxidants and antioxidants in alcohol-induced liver disease Gastroenterology 124 778 790 12612915 10.1053/gast.2003.50087 1:CAS:528:DC%2BD3sXisVKnt74%3D (Pubitemid 36268494)
28. SM Baily C Cunningham 2002 Contribution of mitochondira to oxidative stress associated with alcoholic liver disease Free Radic Biol Med 32 11 16 10.1016/S0891-5849(01)00769-9 (Pubitemid 34045132)
29. L Gloria M Cravo ME Camilo M Resende JN Cardoso AG Oliveria CN Lei Tao FC Mira 1997 Nutritional deficiencies in chronic alcoholics: relation to dietary intake and alcohol consumption Am J Gastroenterol 92 485 489 9068475 1:STN:280:DyaK2s3itFChuw%3D%3D (Pubitemid 27108187)
30. F Stickel D Schuppan EG Hahn HK Seitz 2002 Cocarcinogenic effects of alcohol in hepatocarcinogenesis Gut 51 132 139 12077107 10.1136/gut.51.1.132 1:CAS:528:DC%2BD38XlslOis7o%3D (Pubitemid 34717759)
31. ML Fonda SG Brown MW Pendleton 1989 Concentration of vitamin B6 and activity of enzymes of B6 metabolism in the blood of alcoholic and nonalcoholic men Alc Clin Exper Res 3 804 809 10.1111/j.1530-0277.1989.tb00426.x (Pubitemid 20031161)
32. MM Simile R Pascale MR De Miglio A Nufris L Daino MA Seddaiu L Gaspa F Feo 1994 Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early statges of rat liver carcinogenesis Cancer Lett 79 9 16 7910516 10.1016/0304-3835(94)90056-6 1:CAS:528:DyaK2cXktlaiu7Y%3D (Pubitemid 24146715)
33. WF Zapisek GM Cronin BD Lyn-Cook LA Poirier 1992 The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient amino acid-defined diets Carcinogenesis 13 1869 1872 1330345 10.1093/carcin/13.10.1869 1:CAS:528:DyaK38XmsFSnsbw%3D
34. S Kass D Pruss AP Wolffe 1997 How does DNA methylation repress transcription? Trends Genet 12 444 449 10.1016/S0168-9525(97)01268-7 (Pubitemid 27479903)
35. Y Kondo Y Kanai M Sakamoto M Mizokami R Ueda S Hirohashi 2000 Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on CpG islands in microdissected specimens from patients with HCC Hepatology 32 970 979 11050047 10.1053/jhep.2000.19797 1:CAS:528:DC%2BD3cXot1Wnsr4%3D
36. C Niederau R Fischer A Sonnenberg W Stremmel HJ Trampisch G Strohmeyer 1985 Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis N Engl J Med 313 20 1256 1262 4058506 10.1056/NEJM198511143132004 1:STN:280:DyaL28%2FktVansw%3D%3D (Pubitemid 16217048)
37. PC Adams 1993 Hepatocellular carcinoma in hereditary hemochromatosis Can J C Gastroenterology 7 37 41
38. C Niederau R Fischer A Pürschel W Stremmel D Häussinger G Strohmeyer 1996 Long-term survival in patients with hereditary hemochromatosis Gastroenterology 110 4 1107 1119 8613000 10.1053/gast.1996.v110.pm8613000 1:STN:280:DyaK287otlWnug%3D%3D (Pubitemid 26113751)
39. S Fargion AL Fracanzani A Piperno M Braga R D'Alba G Ronchi G Fiorelli 1994 Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis Hepatology 20 6 1426 1431 7982640 10.1002/hep.1840200608 1:STN:280: DyaK2M%2FntlKrtg%3D%3D (Pubitemid 24359051)
40. WS Cheng S Govindarajan AG Redeker 1992 Hepatocellular carcinoma in a case of Wilson's disease Liver 12 42 45 1314321 1:STN:280:DyaK383islKmuw%3D%3D
41. R Guan CJ Oon PK Wong WC Foong A Wee 1985 Primary hepatocellular carcinoma associated with Wilson's disease in a young woman Postgrad Med J 61 714 357 359 2991870 10.1136/pgmj.61.714.357 1:STN:280:DyaL2M3ntVWhtw%3D%3D (Pubitemid 15113185)
42. J Polio RE Enriquez A Chow WM Wood CE Atterbury 1989 Hepatocellular carcinoma in Wilson's disease. Case report and review of the literature J Clin Gastroenterol 11 220 224 2472436 10.1097/00004836-198904000-00022 1:STN:280:DyaL1M3pt1Gmtw%3D%3D (Pubitemid 19104448)
43. S Eriksson J Carlson R Velez 1986 Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency N Engl J Med 314 12 736 739 3485248 10.1056/NEJM198603203141202 1:STN:280:DyaL287ks1Olug%3D%3D (Pubitemid 16124387)
44. S Erikson 1974 Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency Atca Med Scand 195 451 458 10.1111/j.0954-6820.1974.tb08170.x
45. LN Bull VE Carlton NL Stricker S Baharloo JA DeYoung NB Freimer MS Magid E Kahn J Markowitz FJ DiCarlo L McLoughlin JT Boyle BB Dahms PR Faught JF Fitzgerald DA Piccoli CL Witzleben NC O'Connell KD Setchell RM Agostini Jr. SA Kocoshis J Reyes AS Knisely 1997 Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity Hepatology 26 1 155 164 9214465 10.1002/hep.510260121 1:STN:280:DyaK2szlslWitg%3D%3D (Pubitemid 27280320)
46. B Lindblad S Lindstedt G Steen 1977 On the enzymic defects in hereditary tyrosinemia Proc Natl Acad Sci USA 74 4641 4645 270706 10.1073/pnas.74.10.4641 1:CAS:528:DyaE1cXkt1Wi (Pubitemid 8225182)
47. K Paradis 1996 Tyrosinemia: the Quebec experience Clin Invest Med 195 311 316 (Pubitemid 26354108)
48. F Endo MS Sun 2002 Tyrosinemia type 1 and apoptosis of hepatocytes and renal tubular cells J Inherit Metab Dis 25 227 234 12137232 10.1023/A: 1015646400182 1:CAS:528:DC%2BD38XmtFShsL0%3D (Pubitemid 34700314)